Novel 68Ga-Labeled Peptide PET Tracers Target Gastrin-Releasing Peptide Receptor for Cancer Imaging | Research

The takeaway

Novel 68Ga-labeled GRPR-targeted PET tracers derived from peptide scaffolds showed improved tumor imaging characteristics for prostate and breast cancer diagnosis.

Peptide sees cancer
Novel peptide tracers labeled with gallium-68 enable PET imaging to detect cancers expressing the gastrin-releasing peptide receptor

What the researchers found

Novel 68Ga-labeled GRPR-targeted peptide PET tracers with improved tumor imaging for prostate/breast cancer through optimized peptide scaffold design.

Why it matters

Better cancer imaging leads to earlier detection and more accurate staging, improving treatment outcomes.

How the study worked

Peptide synthesis, 68Ga radiolabeling, GRPR binding affinity, biodistribution, and PET imaging in tumor models.

What this study cannot tell us

Preclinical. Translation to clinical PET imaging needed.

How to read the evidence

Preclinical tracer development with imaging validation.

When this study was published

Published in 2025.

The bigger picture

Peptide-based PET tracers are becoming standard for cancer imaging, with GRPR targeting complementing PSMA imaging for comprehensive prostate cancer evaluation.

Questions still open

How do these tracers compare to existing GRPR imaging agents?
Could they be paired with therapeutic radionuclides for theranostics?
Would combined GRPR+PSMA imaging improve prostate cancer management?

Common questions

How do peptides help find cancer?

Peptides that bind to specific cancer cell receptors (GRPR) are labeled with radioactive gallium-68. When injected, they concentrate at tumors and light up on PET scans for precise cancer detection.

Which cancers can this detect?

GRPR is overexpressed in prostate, breast, and other cancers. These peptide tracers provide a non-invasive way to detect and stage these tumors.

Read the original research

Synthesis and Evaluation of Novel 68Ga-Labeled GRPR-Targeted PET Tracers Derived from [d-Phe6,Pro14]Bombesin(6-14) and [d-Phe6,des-Met14]Bombesin(6-14) Sequences.

Molecular pharmaceutics, 23(3), 1985-1995

View on PubMed ↗Publisher’s paper ↗

Citation

Jozi, Shireen; Pathania, Sheetal; Wang, Lei; Chen, Chao-Cheng; Lau, Wing Sum; Ng, Pauline; Merkens, Helen; Bénard, François; Lin, Kuo-Shyan. (2026). Synthesis and Evaluation of Novel 68Ga-Labeled GRPR-Targeted PET Tracers Derived from [d-Phe6,Pro14]Bombesin(6-14) and [d-Phe6,des-Met14]Bombesin(6-14) Sequences.. Molecular pharmaceutics, 23(3), 1985-1995. https://doi.org/10.1021/acs.molpharmaceut.5c01683